SELARL GRANDE PHARMACIE DE LA FONTONNE : revenue, balance sheet and financial ratios

SELARL GRANDE PHARMACIE DE LA FONTONNE is a French company founded 21 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANTIBES (06600), this company of category PME shows in 2019 a revenue of 3.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL GRANDE PHARMACIE DE LA FONTONNE (SIREN 482019791)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C 3 736 153 € 3 648 012 € 3 526 615 € 3 453 290 €
Net income -22 424 € 179 765 € 144 047 € 318 790 € -299 805 € 164 936 € 169 896 € 149 814 € 162 804 €
EBITDA N/C N/C N/C N/C N/C 278 210 € 278 584 € 260 121 € 219 931 €
Net margin N/C N/C N/C N/C N/C 4.4% 4.7% 4.2% 4.7%

Revenue and income statement

In 2024, SELARL GRANDE PHARMACIE DE LA FONTONNE records a net loss of 22 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-22 424 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

48.688%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

55.947%

Solvency indicators evolution
SELARL GRANDE PHARMACIE DE LA FONTONNE

Sector positioning

Debt ratio
48.69 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good +6 pts over 3 years

In 2024, the debt ratio of SELARL GRANDE PHARMACIE D... (48.69) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
55.95% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good -7 pts over 3 years

In 2024, the financial autonomy of SELARL GRANDE PHARMACIE D... (56.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL GRANDE PHARMACIE DE LA FONTONNE

Positioning of SELARL GRANDE PHARMACIE DE LA FONTONNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL GRANDE PHARMACIE DE LA FONTONNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL GRANDE PHARMACIE DE LA FONTONNE

What is the revenue of SELARL GRANDE PHARMACIE DE LA FONTONNE ?

The revenue of SELARL GRANDE PHARMACIE DE LA FONTONNE in 2019 is 3.7 M€.

Is SELARL GRANDE PHARMACIE DE LA FONTONNE profitable?

SELARL GRANDE PHARMACIE DE LA FONTONNE recorded a net loss in 2024.

Where is the headquarters of SELARL GRANDE PHARMACIE DE LA FONTONNE ?

The headquarters of SELARL GRANDE PHARMACIE DE LA FONTONNE is located in ANTIBES (06600), in the department Alpes-Maritimes.

Where to find the tax return of SELARL GRANDE PHARMACIE DE LA FONTONNE ?

The tax return of SELARL GRANDE PHARMACIE DE LA FONTONNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL GRANDE PHARMACIE DE LA FONTONNE operate?

SELARL GRANDE PHARMACIE DE LA FONTONNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.